13F Data
13F filer · CIK 1560009

Versant Venture Management, LLC

San Francisco, CA · filing since Q4 2014 · last filing Aug 12, 2026
Reported value
$162.6M
+$21.2M vs prior
Positions
8
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $11.9M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedJade Biosciences, Inc.-534,037-35.0%$-11.9M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $104.6MQ1 2015: $113.7MQ2 2015: $78.8MQ3 2015: $174.4MQ4 2015: $170.9MQ1 2016: $138.5MQ2 2016: $98.7MQ3 2016: $89.7MQ4 2016: $102.7MQ1 2017: $137.5MQ2 2017: $127.1MQ3 2017: $131.4MQ4 2017: $95.0MQ1 2018: $312.7MQ2 2018: $320.5MQ3 2018: $294.0MQ4 2018: $202.0MQ1 2019: $303.6MQ2 2019: $343.2MQ3 2019: $258.5MQ4 2019: $331.8MQ1 2020: $364.6MQ2 2020: $696.1MQ3 2020: $546.4MQ4 2020: $963.0MQ1 2021: $513.3MQ2 2021: $301.8MQ3 2021: $241.5MQ4 2021: $187.0MQ1 2022: $100.2MQ2 2022: $65.2MQ3 2022: $58.7MQ4 2022: $48.3MQ1 2023: $48.0MQ2 2023: $84.3MQ3 2023: $188.1MQ4 2023: $388.8MQ1 2024: $103.1MQ2 2024: $77.3MQ3 2024: $63.6MQ4 2024: $86.7MQ1 2025: $60.2MQ2 2025: $82.1MQ3 2025: $212.5MQ4 2025: $151.1MQ1 2026: $141.4MQ2 2026: $162.6M
Q4 2014Q2 2026

Holdings · Q2 2026